Ryan Bond
Corporate Officer/Principal at ACLARION, INC.
Net worth: 357 $ as of 2024-06-29
Profile
Ryan Bond is currently the Chief Strategy Officer at Aclarion, Inc. He previously worked as the Director-Healthcare Solutions at NuVasive, Inc. from 2014 to 2018.
Mr. Bond completed his undergraduate degree at The Ohio University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ACLARION, INC.
0.02% | 2023-09-29 | 1,250 ( 0.02% ) | 358 $ | 2024-06-29 |
Ryan Bond active positions
| Companies | Position | Start |
|---|---|---|
| ACLARION, INC. | Corporate Officer/Principal | 2021-09-14 |
Former positions of Ryan Bond
| Companies | Position | End |
|---|---|---|
| NUVASIVE, INC. | Corporate Officer/Principal | 2018-08-31 |
Training of Ryan Bond
| The Ohio University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ACLARION, INC. | Technology Services |
| Private companies | 1 |
|---|---|
NuVasive, Inc.
 NuVasive, Inc. Medical SpecialtiesHealth Technology NuVasive, Inc. engages in the development, manufacture, sale, and provision of procedural solutions for spine surgery. It offers a comprehensive portfolio of procedurally integrated spine surgery solutions, including surgical access instruments, spinal implants, fixation systems, biologics, and enabling technologies, as well as systems and services for intraoperative neuromonitoring. The company was founded by Alexis V. Lukianov on July 21, 1997 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Ryan Bond
